pubmed-article:20131260 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20131260 | lifeskim:mentions | umls-concept:C1862852 | lld:lifeskim |
pubmed-article:20131260 | lifeskim:mentions | umls-concept:C0002085 | lld:lifeskim |
pubmed-article:20131260 | lifeskim:mentions | umls-concept:C1416652 | lld:lifeskim |
pubmed-article:20131260 | lifeskim:mentions | umls-concept:C1416654 | lld:lifeskim |
pubmed-article:20131260 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
pubmed-article:20131260 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:20131260 | pubmed:dateCreated | 2010-4-14 | lld:pubmed |
pubmed-article:20131260 | pubmed:abstractText | The killer cell immunoglobulin-like receptors (KIRs) form a group of regulatory molecules that specifically recognize HLA class I molecules. The aim of this study was to analyze the possible contribution of the KIR3DL1 and KIR3DS1 alleles, in addition to HLA-B27, in the susceptibility to ankylosing spondylitis (AS) in a population of individuals from Spain. | lld:pubmed |
pubmed-article:20131260 | pubmed:language | eng | lld:pubmed |
pubmed-article:20131260 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20131260 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:20131260 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20131260 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20131260 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20131260 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20131260 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20131260 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20131260 | pubmed:month | Apr | lld:pubmed |
pubmed-article:20131260 | pubmed:issn | 1529-0131 | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:SolanaRafaelR | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:VicarioJose... | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:López-Vázquez... | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:Martínez-Borr... | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:López-LarreaC... | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:CollantesEdua... | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:Suarez-Alvare... | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:Díaz-PeñaRobe... | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:Alonso-AriasR... | lld:pubmed |
pubmed-article:20131260 | pubmed:author | pubmed-author:Vidal-Castiñe... | lld:pubmed |
pubmed-article:20131260 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20131260 | pubmed:volume | 62 | lld:pubmed |
pubmed-article:20131260 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20131260 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20131260 | pubmed:pagination | 1000-6 | lld:pubmed |
pubmed-article:20131260 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:meshHeading | pubmed-meshheading:20131260... | lld:pubmed |
pubmed-article:20131260 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20131260 | pubmed:articleTitle | Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. | lld:pubmed |
pubmed-article:20131260 | pubmed:affiliation | Hospital Universitario Central de Asturias, 33006-Oviedo, Spain. | lld:pubmed |
pubmed-article:20131260 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20131260 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:3811 | entrezgene:pubmed | pubmed-article:20131260 | lld:entrezgene |
entrez-gene:3813 | entrezgene:pubmed | pubmed-article:20131260 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20131260 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20131260 | lld:entrezgene |